These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27696867)

  • 1. Fecal Metabolome in Hmga1 Transgenic Mice with Polyposis: Evidence for Potential Screen for Early Detection of Precursor Lesions in Colorectal Cancer.
    Williams MD; Xian L; Huso T; Park JJ; Huso D; Cope LM; Gang DR; Siems WF; Resar L; Reeves R; Hill HH
    J Proteome Res; 2016 Dec; 15(12):4176-4187. PubMed ID: 27696867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMGA1 drives metabolic reprogramming of intestinal epithelium during hyperproliferation, polyposis, and colorectal carcinogenesis.
    Williams MD; Zhang X; Belton AS; Xian L; Huso T; Park JJ; Siems WF; Gang DR; Resar LM; Reeves R; Hill HH
    J Proteome Res; 2015 Mar; 14(3):1420-31. PubMed ID: 25643065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal Fatty Acid Profiling as a Potential New Screening Biomarker in Patients with Colorectal Cancer.
    Song EM; Byeon JS; Lee SM; Yoo HJ; Kim SJ; Lee SH; Chang K; Hwang SW; Yang DH; Jeong JY
    Dig Dis Sci; 2018 May; 63(5):1229-1236. PubMed ID: 29516324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal volatile organic compounds for early detection of colorectal cancer: where are we now?
    Bosch S; Berkhout DJ; Ben Larbi I; de Meij TG; de Boer NK
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):223-234. PubMed ID: 30554400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing metabolic changes in human colorectal cancer.
    Williams MD; Zhang X; Park JJ; Siems WF; Gang DR; Resar LM; Reeves R; Hill HH
    Anal Bioanal Chem; 2015 Jun; 407(16):4581-95. PubMed ID: 25943258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer.
    Lin Y; Ma C; Liu C; Wang Z; Yang J; Liu X; Shen Z; Wu R
    Oncotarget; 2016 May; 7(20):29454-64. PubMed ID: 27107423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quantitative multimodal metabolomic assay for colorectal cancer.
    Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
    BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic profiling, a noninvasive approach for the detection of experimental colorectal neoplasia.
    Montrose DC; Zhou XK; Kopelovich L; Yantiss RK; Karoly ED; Subbaramaiah K; Dannenberg AJ
    Cancer Prev Res (Phila); 2012 Dec; 5(12):1358-67. PubMed ID: 22961778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum metabolite profiling of familial adenomatous polyposis using ultra performance liquid chromatography and tandem mass spectrometry.
    Sun L; Kang Q; Pan Y; Li N; Wang X; He Y; Wang H; Yu D; Xie H; Yang L; Lu Y; Jin P; Sheng J
    Cancer Biol Ther; 2019; 20(7):1017-1028. PubMed ID: 30983515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Proton nuclear magnetic resonance spectroscopy recognition of metabolic patterns in fecal extracts for early diagnosis of colorectal cancer].
    Lin Y; Wang ZN; Ma CC; Liu CK; Yang JR; Shen ZW; Wu RH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Sep; 50(9):788-793. PubMed ID: 27655598
    [No Abstract]   [Full Text] [Related]  

  • 11.
    Lin Y; Ma C; Bezabeh T; Wang Z; Liang J; Huang Y; Zhao J; Liu X; Ye W; Tang W; Ouyang T; Wu R
    Int J Cancer; 2019 Sep; 145(6):1679-1689. PubMed ID: 30720869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative plasma and fecal metabolomics identify functional metabolites in adenoma-colorectal cancer progression and as early diagnostic biomarkers.
    Sun Y; Zhang X; Hang D; Lau HC; Du J; Liu C; Xie M; Pan Y; Wang L; Liang C; Zhou X; Chen D; Rong J; Zhao Z; Cheung AH; Wu Y; Gou H; Wong CC; Du L; Deng J; Hu Z; Shen H; Miao Y; Yu J
    Cancer Cell; 2024 Aug; 42(8):1386-1400.e8. PubMed ID: 39137727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigations in the possibility of early detection of colorectal cancer by gas chromatography/triple-quadrupole mass spectrometry.
    Nishiumi S; Kobayashi T; Kawana S; Unno Y; Sakai T; Okamoto K; Yamada Y; Sudo K; Yamaji T; Saito Y; Kanemitsu Y; Okita NT; Saito H; Tsugane S; Azuma T; Ojima N; Yoshida M
    Oncotarget; 2017 Mar; 8(10):17115-17126. PubMed ID: 28179577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiome-metabolomic analysis of the impact of Zizyphus jujuba cv. Muzao polysaccharides consumption on colorectal cancer mice fecal microbiota and metabolites.
    Ji X; Hou C; Zhang X; Han L; Yin S; Peng Q; Wang M
    Int J Biol Macromol; 2019 Jun; 131():1067-1076. PubMed ID: 30926487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.
    Ritchie SA; Ahiahonu PW; Jayasinghe D; Heath D; Liu J; Lu Y; Jin W; Kavianpour A; Yamazaki Y; Khan AM; Hossain M; Su-Myat KK; Wood PL; Krenitsky K; Takemasa I; Miyake M; Sekimoto M; Monden M; Matsubara H; Nomura F; Goodenowe DB
    BMC Med; 2010 Feb; 8():13. PubMed ID: 20156336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum metabolomics analysis for early detection of colorectal cancer.
    Uchiyama K; Yagi N; Mizushima K; Higashimura Y; Hirai Y; Okayama T; Yoshida N; Katada K; Kamada K; Handa O; Ishikawa T; Takagi T; Konishi H; Kuriu Y; Nakanishi M; Otsuji E; Itoh Y; Naito Y
    J Gastroenterol; 2017 Jun; 52(6):677-694. PubMed ID: 27650200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Profiling of Fecal Metabolome of Mice by Integrated Chemical Isotope Labeling-Mass Spectrometry Analysis.
    Yuan BF; Zhu QF; Guo N; Zheng SJ; Wang YL; Wang J; Xu J; Liu SJ; He K; Hu T; Zheng YW; Xu FQ; Feng YQ
    Anal Chem; 2018 Mar; 90(5):3512-3520. PubMed ID: 29406693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMGA1 induces intestinal polyposis in transgenic mice and drives tumor progression and stem cell properties in colon cancer cells.
    Belton A; Gabrovsky A; Bae YK; Reeves R; Iacobuzio-Donahue C; Huso DL; Resar LM
    PLoS One; 2012; 7(1):e30034. PubMed ID: 22276142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults.
    Weir TL; Manter DK; Sheflin AM; Barnett BA; Heuberger AL; Ryan EP
    PLoS One; 2013; 8(8):e70803. PubMed ID: 23940645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMGA1 overexpression in adipose tissue impairs adipogenesis and prevents diet-induced obesity and insulin resistance.
    Arce-Cerezo A; García M; Rodríguez-Nuevo A; Crosa-Bonell M; Enguix N; Peró A; Muñoz S; Roca C; Ramos D; Franckhauser S; Elias I; Ferre T; Pujol A; Ruberte J; Villena JA; Bosch F; Riu E
    Sci Rep; 2015 Sep; 5():14487. PubMed ID: 26411793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.